Lv1
70 积分 2025-06-23 加入
Pembrolizumab in HER2-Positive Gastric Cancer
2个月前
已完结
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
3个月前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
7个月前
已完结
Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells
7个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
8个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
8个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
8个月前
已完结
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
10个月前
已完结
Single-cell profiling reveals altered immune landscape and impaired NK cell function in gastric cancer liver metastasis
10个月前
已完结
皖公网安备34019202002308
